N-[[1-[(2-Nitrophenyl)sulfonyl]-1H-indole-3-yl]methyl]-N-[1-[1-[(2-nitrophenyl)sulfonyl]-1H-indole-3-yl]-2-oxo-2-(tert-butylamino)ethyl]-1-(2-diazo-3-oxobutyryl)-2-oxo-3-methylpiperidine-3beta-carboxamideCAS# 151513-70-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 151513-70-1 | SDF | Download SDF |
PubChem ID | 101485908 | Appearance | Powder |
Formula | C46H43N9O13S2 | M.Wt | 994 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 4-[(3R)-3-[[2-(tert-butylamino)-1-[1-(2-nitrophenyl)sulfonylindol-3-yl]-2-oxoethyl]-[[1-(2-nitrophenyl)sulfonylindol-3-yl]methyl]carbamoyl]-3-methyl-2-oxopiperidin-1-yl]-3-diazonio-4-oxobut-2-en-2-olate | ||
SMILES | CC(=C(C(=O)N1CCCC(C1=O)(C)C(=O)N(CC2=CN(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4[N+](=O)[O-])C(C5=CN(C6=CC=CC=C65)S(=O)(=O)C7=CC=CC=C7[N+](=O)[O-])C(=O)NC(C)(C)C)[N+]#N)[O-] | ||
Standard InChIKey | JWZJJGGNYWXDKK-BONLUEMTSA-N | ||
Standard InChI | InChI=1S/C46H43N9O13S2/c1-28(56)39(49-47)42(58)50-24-14-23-46(5,43(50)59)44(60)51(25-29-26-52(33-17-8-6-15-30(29)33)69(65,66)37-21-12-10-19-35(37)54(61)62)40(41(57)48-45(2,3)4)32-27-53(34-18-9-7-16-31(32)34)70(67,68)38-22-13-11-20-36(38)55(63)64/h6-13,15-22,26-27,40H,14,23-25H2,1-5H3,(H-,48,56,57,58)/t40?,46-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
N-[[1-[(2-Nitrophenyl)sulfonyl]-1H-indole-3-yl]methyl]-N-[1-[1-[(2-nitrophenyl)sulfonyl]-1H-indole-3-yl]-2-oxo-2-(tert-butylamino)ethyl]-1-(2-diazo-3-oxobutyryl)-2-oxo-3-methylpiperidine-3beta-carboxamide Dilution Calculator
N-[[1-[(2-Nitrophenyl)sulfonyl]-1H-indole-3-yl]methyl]-N-[1-[1-[(2-nitrophenyl)sulfonyl]-1H-indole-3-yl]-2-oxo-2-(tert-butylamino)ethyl]-1-(2-diazo-3-oxobutyryl)-2-oxo-3-methylpiperidine-3beta-carboxamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.006 mL | 5.0302 mL | 10.0604 mL | 20.1207 mL | 25.1509 mL |
5 mM | 0.2012 mL | 1.006 mL | 2.0121 mL | 4.0241 mL | 5.0302 mL |
10 mM | 0.1006 mL | 0.503 mL | 1.006 mL | 2.0121 mL | 2.5151 mL |
50 mM | 0.0201 mL | 0.1006 mL | 0.2012 mL | 0.4024 mL | 0.503 mL |
100 mM | 0.0101 mL | 0.0503 mL | 0.1006 mL | 0.2012 mL | 0.2515 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ampelopsin F
Catalog No.:BCN3305
CAS No.:151487-08-0
- Swietemahalactone
Catalog No.:BCN6886
CAS No.:1514669-21-6
- Estradiol hexahydrobenzoate
Catalog No.:BCC8962
CAS No.:15140-27-9
- Pseudolarolide B
Catalog No.:BCN8093
CAS No.:151368-43-3
- Ro 32-0432 hydrochloride
Catalog No.:BCC7122
CAS No.:151342-35-7
- 3-O-p-Coumaroyloleanolic acid
Catalog No.:BCN3952
CAS No.:151334-06-4
- Zaleplon
Catalog No.:BCC5197
CAS No.:151319-34-5
- Inokosterone
Catalog No.:BCN3431
CAS No.:15130-85-5
- Genkwanol C
Catalog No.:BCN8012
CAS No.:151283-11-3
- CP 135807
Catalog No.:BCC7774
CAS No.:151272-90-1
- Primin
Catalog No.:BCN2729
CAS No.:15121-94-5
- Poricoic acid AM
Catalog No.:BCN8499
CAS No.:151200-92-9
- Levomefolate calcium
Catalog No.:BCC1702
CAS No.:151533-22-1
- RU 58668
Catalog No.:BCC7608
CAS No.:151555-47-4
- ent-3-Oxokauran-17-oic acid
Catalog No.:BCN1674
CAS No.:151561-88-5
- JJKK 048
Catalog No.:BCC5610
CAS No.:1515855-97-6
- XEN445
Catalog No.:BCC5382
CAS No.:1515856-92-4
- 6-Prenylquercetin-3-methylether
Catalog No.:BCN7992
CAS No.:151649-34-2
- H-D-Ser-OBzl.HCl
Catalog No.:BCC3097
CAS No.:151651-44-4
- SEP-0372814
Catalog No.:BCC6429
CAS No.:1516895-53-6
- 5-Deoxystrigol
Catalog No.:BCN7693
CAS No.:151716-18-6
- 2,2-Dimethyl-8-prenylchromene 6-carboxylic acid
Catalog No.:BCN1675
CAS No.:151731-50-9
- 4,4'-Dihydroxy-2,6-dimethoxydihydrochalcone
Catalog No.:BCN3583
CAS No.:151752-08-8
- Montelukast Sodium
Catalog No.:BCC4680
CAS No.:151767-02-1
Involvement of MAPK, Bcl-2 family, cytochrome c, and caspases in induction of apoptosis by 1,6-O,O-diacetylbritannilactone in human leukemia cells.[Pubmed:17262884]
Mol Nutr Food Res. 2007 Feb;51(2):229-38.
1,6-O,O-diacetylbritannilactone (OODBL) isolated from Inula britannica, exhibits potent antitumor activity against several human cancer cell lines. However, the molecular mechanism of OODBL in the induction of anticancer activity is still unclear. In the present study, we demonstrated that OODBL induced the occurrence of apoptosis in human leukemic (HL-60) cells and cell arrest at the S phase. On the other hand, activation of caspase-8, -9, and -3, phosphorylation of Bcl-2 and Bid, and increased release of cytochrome c from mitochondria into cytosolic fraction were detected in OODBL-treated HL-60 cells. We further demonstrated that production of reactive oxygen species (ROS), activation of mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) signaling pathways may play an important role in OODBL-induced apoptosis. The results from the present study highlight the molecular mechanisms underlying OODBL-induced anticancer activity.
Cytotoxic and Pro-apoptotic Activities of Sesquiterpene Lactones from Inula britannica.[Pubmed:26996005]
Nat Prod Commun. 2016 Jan;11(1):7-10.
In this study, five known sesquiterpene lactones (STL) with an alpha-methylene-gamma-lactone motif, including two eudesmanolides, 1beta-hydroxyalantolactone (1) and ivangustin (2), and three 1,10-seco-eudesmanolides, 1-O-acetylbritannilactone (3), 1,6-O,O-diacetylbritannilactone (4), and 6alpha-O-(2- methylbutyryl)britannilactone (5) were isolated from the flower heads of the medicinal plant Inula britannica. Their structures were characterized by spectroscopic methods. X-ray data of 2 is reported for the first time. Among them, eudesmanolides 1 and 2 exhibited remarkable cytotoxicity against HEp2, SGC-7901 and HCT116 human cancer cell lines, comparable with etoposide (Vp-16) used as reference drug. Furthermore, treatment of HEp2 cells with 1 induced apoptosis associated with cleaved procaspase-3 and PARP. The biological assays carried out with normal cells (CHO) revealed that all sesquiterpenes were weakly selective against the cancer cell lines tested.
1,6-O,O-diacetylbritannilactones inhibits IkappaB kinase beta-dependent NF-kappaB activation.[Pubmed:18926678]
Phytomedicine. 2009 Mar;16(2-3):156-60.
To determine the chemical constituents responsible for pharmacological effects of Inula britannica-F., three specific sesquiterpene lactones in Inula britannica were isolated from chloroform extract and identified, including britannilactone (BL), 1-O-acetylbritannilactone (ABLO), and 1,6-O,O-diacetylbritannilactone (ABLOO). Electrophoretic mobility shift assay (EMSA) was performed to detect the nuclear translocation of nuclear factor-kappaB (NF-kappaB) p65. The expressions of IkappaBalpha, pIkappaBalpha, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), IkappaB kinase alpha/beta (IKKalpha/beta) and NF-kappaB kinase (NIK) were detected by Western blot and RT-PCR. We found that acetyl side groups enhanced the inhibitory action of the agents on LPS/IFN-gamma-induced iNOS and COX-2 expression. Their inhibiting activity was positive correlation with the acetyl side group number. The effects of LPS/IFN-gamma were reversed by ABLOO, and BL without acetyl side groups showed only a weak inhibitory action. Further study indicated that ABLOO markedly inhibited the phosphorylation of IKKbeta down to based level, but not IKKalpha, corresponding with decreased in IkappaBalpha degradation and phosphorylation induced by LPS/IFN-gamma, resulting in the suppression of NF-kappaB nuclear translocation and activity. These results suggest that the acetyl moieties add to the lipophilicity, and consequently enhance cellular penetration, so that ABLOO possess the most anti-inflammatory effect and may be a potent lead structure for the development of therapeutic and cytokine-suppressing remedies valuable for the treatment of various inflammatory diseases.